Publications for Raymond Sy 2016

Publications for Raymond Sy
Publications for Raymond Sy
Phan, K., Ha, H., Kabunga, P., Kilborn, M.,
Toal, E., Sy, R. (2016). Systematic review of
defibrillation threshold testing at de novo
implantation. Circulation. Arrhythmia and
Electrophysiology, 9(4), 1-9. <a
3357">[More Information]</a>
Kabunga, P., Lipton, J., Sy, R. (2015).
Adenosine-Sensitive Ventricular Tachycardia
arising from the Middle Cardiac Vein. Heart,
Lung and Circulation, 24, 838-839. <a
1">[More Information]</a>
Lipton, J., Klein, G., Sy, R. (2015). Challenges
in the diagnosis and management of idiopathic
ventricular fibrillation. HeartRhythm Case
Reports, 1(5), 269-274. <a
8">[More Information]</a>
Phan, K., Kabunga, P., Kilborn, M., Sy, R.
(2015). Defibrillator Threshold Testing at
Generator Replacement: Is it Time to Abandon
the Practice? PACE - Pacing and Clinical
Electrophysiology, 38(7), 777-781. <a
ore Information]</a>
Lau, J., Sy, R., Corbett, A., Kritharides, L.
(2015). Myotonic dystrophy and the heart: A
systematic review of evaluation and
management. International Journal of
Cardiology, 184, 600-608. <a
069">[More Information]</a>
Vaidya, K., Arnott, C., Russell, A., Masson, P.,
Sy, R., Patel, S. (2015). Pulmonary Vein
Isolation Compared to Rate Control in Patients
with Atrial Fibrillation: A Systematic Review
and Meta-analysis. Heart, Lung and Circulation,
24(8), 744-752. <a
5">[More Information]</a>
Kabunga, P., Lau, A., Phan, K., Puranik, R.,
Liang, C., Davis, R., Sue, C., Sy, R. (2015).
Systematic review of cardiac electrical disease in
Kearns-Sayre syndrome and mitochondrial
cytopathy. International Journal of Cardiology,
181, 303-310. <a
038">[More Information]</a>
Common ECG Phenotype? Journal of
Cardiovascular Electrophysiology, 25(4),
450-456. <a
e Information]</a>
Lowres, N., Neubeck, A., Salkeld, G., Krass, I.,
McLachlan, A., Redfern, J., Bennett, A., Briffa,
T., Bauman, A., Martinez, C., Lau, J., Brieger,
D., Sy, R., Freedman, B., et al (2014). Feasibility
and cost effectiveness of stroke prevention
through community screening for atrial
fibrillation using iPhone ECG in pharmacies:
The SEARCH-AF study. Thrombosis and
Haemostasis, 111(6), 1167-1176. <a
>[More Information]</a>
Ghosh, J., McGuire, M., Kilborn, M., Singarayar,
S., Medi, C., Sy, R. (2014). Shock-resistant
ventricular fibrillation. International Journal of
Kabunga, P., Hodkinson, E., Sy, R. (2014). What
is the mechanism of tachycardia? Heart, 100(24),
1924-1932, 1986. <a
6328">[More Information]</a>
Lau, J., Lowres, N., Neubeck, A., Brieger, D.,
Sy, R., Galloway, C., Albert, D., Freedman, B.
(2013). iPhone ECG application for community
screening to detect silent atrial fibrillation:
A novel technology to prevent stroke.
International Journal of Cardiology, 165(1),
193-194. <a
220">[More Information]</a>
Lowres, N., Neubeck, A., Redfern, J.,
McLachlan, A., Krass, I., Bennett, A., Briffa, T.,
Salkeld, G., Brieger, D., Sy, R., Bauman, A.,
Freedman, B. (2013). Screening Education and
Recognition in Community Pharmacies of Atrial
Fibrillation to Prevent stroke (SEARCH-AF
Stroke Prevention Study). 61st Annual Scientific
Meeting of the Cardiac Society of Australia and
New Zealand (CSANZ) 2013, Gold Coast,
Queensland, Australia. <a
2">[More Information]</a>
Chan, K., Sy, R. (2013). Toward permanent
pulmonary vein isolation: The use of adenosine
to unmask dormant conduction. Heart Rhythm,
10(5), 636-637. <a
037">[More Information]</a>
Gray, B., Semsarian, C., Sy, R. (2014). Brugada
Syndrome: A Heterogeneous Disease with a
Sy, R., Krahn, A. (2012). Exercise testing: the
catecholaminergic polymorphic ventricular
Publications for Raymond Sy
tachycardia crystal ball? Europace, 14(9),
1225-1227. <a
">[More Information]</a>
Sy, R., Thiagalingam, A., Stiles, M. (2012).
Modern Electrophysiology Mapping Techniques.
Heart, Lung and Circulation, 21(6-7), 364-375.
7">[More Information]</a>
Obeyesekere, M., Sy, R., Modi, S. (2012). When
can ablation be considered a reasonable option in
young asymptomatic patients with a
Wolff-Parkinson-White ECG? Expert Review of
Cardiovascular Therapy, 10(12), 1451-1453. <a
re Information]</a>
Sy, R., Chawantanpipat, C., Richmond, D.,
Kritharides, L. (2011). Development and
validation of a time-dependent risk model for
predicting mortality in infective endocarditis.
European Heart Journal, 32, 2016-2026. <a
">[More Information]</a>
Sy, R., Kritharides, L. (2010). Health care
exposure and age in infective endocarditis:
results of a contemporary population-based
profile of 1536 patients in Australia. European
Heart Journal, 31(15), 1890-1897. <a
">[More Information]</a>
Burgess, D., Hunt, D., Li, L., Zannino, D.,
Williamson, E., Davis, T., Laakso, M.,
Kesaniemi, Y., Zhang, J., Sy, R., Keech, A., et al
(2010). Incidence and predictors of silent
myocardial infarction in type 2 diabetes and the
effect of fenofibrate: an analysis from the
Fenofibrate Intervention and Event Lowering in
Diabetes (FIELD) study. European Heart
Journal, 31(1), 92-99. <a
">[More Information]</a>
Sy, R., Bannon, P., Bayfield, M., Brown, C.,
Kritharides, L. (2009). Survivor Treatment
Selection Bias and Outcomes Research: A Case
Study of Surgery in Infective Endocarditis.
Circulation. Cardiovascular Quality and
Outcomes, 2(5), 469-474. <a
ES.109.857938">[More Information]</a>